The Kirby Institute has been a key player in NSW’s partnership response to HIV, which has reached a historic milestone.
Research from The Kirby Institute released for World Hepatitis Day shows Australia could be one of the first countries in the world to eliminate hepatitis C.
Research from The Kirby Institute adds to the evidence that effectively treating HIV blocks transmission in couples of differing HIV status.
Infection and immunity researcher Anthony Kelleher from the Kirby Institute has been welcomed as Acting Dean of UNSW Medicine.
The Kirby Institute's Rebecca Guy is the fourth outstanding woman researcher from UNSW to win the Elizabeth Blackburn Fellowship in the past three years.
The Kirby Institute's new research collaboration with Myanmar's University of Medicine 2 will build research capacity in infectious diseases in the country, which faces considerable health challenges.
More Australians have been treated for hepatitis C in the past 12 months than the last decade combined, following the listing of a new generation therapy on the Pharmaceutical Benefits Scheme.
Clinical trials for childhood cancer and studies into pain medicine addiction and teenagers living with OCD are among UNSW projects to receive backing from the NHMRC.
For their work in surface chemistry, HIV/AIDS and memory disruption in dementia, three UNSW researchers have won four prestigious Royal Society of NSW Awards for 2016.
A UNSW research trial to examine if e-cigarettes can help smokers quit and a world-first treatment for teenagers with PTSD and substance abuse are among projects to receive major backing in the latest NHMRC funding round.